2006
DOI: 10.1097/01.mjt.0000208876.69103.c7
|View full text |Cite
|
Sign up to set email alerts
|

Methemoglobinemia-induced Cardio-respiratory Failure Secondary to Topical Anesthesia

Abstract: Acute toxic methemoglobinemia is an infrequent complication of the use of topical anesthetics, most notably benzocaine. The clinical picture is characterized by sudden development of tissue hypoxia without underlying cardiac or respiratory dysfunction, and deceptively normal oxygen saturation on conventional arterial blood gas analysis. This condition may be rapidly fatal and management depends upon prompt recognition, confirmation of clinical suspicion using cooximetry of arterial blood, and quick institution… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 11 publications
0
11
0
1
Order By: Relevance
“…In RBCs, there are both major (95%) and minor (5%) pathways to reduce methemoglobin back to its oxygen-carrying state. Cytochrome-b 5 reductase (also known as NADH methemoglobin reductase) is the primary pathway involved in this reduction [1][2][3][4][5]. An additional enzyme, nicotinamide adenine dinucleotide phosphate (NADPH) methemoglobin reductase, is also capable of reducing methemoglobin; although its activity is quite limited during normal physiologic conditions, it becomes highly significant in the presence of methylene blue (see Fig.…”
Section: What Is the Pathophysiologic Basis For Methemoglobin Formation?mentioning
confidence: 99%
See 4 more Smart Citations
“…In RBCs, there are both major (95%) and minor (5%) pathways to reduce methemoglobin back to its oxygen-carrying state. Cytochrome-b 5 reductase (also known as NADH methemoglobin reductase) is the primary pathway involved in this reduction [1][2][3][4][5]. An additional enzyme, nicotinamide adenine dinucleotide phosphate (NADPH) methemoglobin reductase, is also capable of reducing methemoglobin; although its activity is quite limited during normal physiologic conditions, it becomes highly significant in the presence of methylene blue (see Fig.…”
Section: What Is the Pathophysiologic Basis For Methemoglobin Formation?mentioning
confidence: 99%
“…In contrast, NADPH methemoglobin reductase utilizes NADPH formed by the hexose monophosphate shunt by the enzyme glucose-6-phosphate dehydrogenase (G6PD) to reduce methylene blue to leukomethylene blue, which in turn donates an electron to reduce methemoglobin [6]. As discussed below, a deficiency in G6PD has important implications for the treatment of methemoglobinemia [1,4].…”
Section: What Is the Pathophysiologic Basis For Methemoglobin Formation?mentioning
confidence: 99%
See 3 more Smart Citations